M&A

Abbott and Bigfoot Take Relationship to the Next Level
Medical Devices and Diagnostics Industry
Tue, 09/5/23 - 08:49 pm
Abbott Labs
Bigfoot Biomedical
M&A
Medtech
diabetes
Years after $2B buyout, Nestlé ditches Aimmune's peanut allergy drug Palforzia
Fierce Pharma
Tue, 09/5/23 - 11:32 am
Nestle
Palforzia
peanut allergy
M&A
Stallergenes Greer
FTC allows Amgen’s $27.8B purchase of Horizon to proceed
Medical Marketing and Media
Fri, 09/1/23 - 12:40 pm
FTC
Amgen
Horizon Therapeutics
M&A
Johnson & Johnson's spinoff of Kenvue provides $13.2B in potential M&A firepower
Fierce Pharma
Wed, 08/30/23 - 11:29 pm
JNJ
M&A
consumer health
Kenvue
Novo Bolsters Obesity Pipeline with Potential $500M Embark Biotech Buy
BioSpace
Wed, 08/30/23 - 11:22 am
Novo Nordisk
Embark Biotech
obesity
M&A
FTC Temporarily Withdraws Challenge to $27.8B Amgen-Horizon Deal
BioSpace
Mon, 08/28/23 - 12:06 pm
FTC
Amgen
Horizon Therapeutics
M&A
After Catalent rumors, Danaher strikes $5.7B deal to acquire antibody specialist Abcam
Fierce Pharma
Mon, 08/28/23 - 12:00 pm
Danaher
Abcam
antibodies
M&A
'Far too speculative': Amgen fights FTC's request for injunction against $28B Horizon merger
Fierce Pharma
Thu, 08/24/23 - 11:38 am
Amgen
Horizon Therapeutics
M&A
FTC
LEO Pharma to Acquire Timber Pharmaceuticals
Dermatology Times
Mon, 08/21/23 - 07:58 pm
LEO Pharma
M&A
Timber Pharmaceuticals
dermatology
Stada CEO Confirms Buyout Rumors, Sale Could Potentially Fetch $11B
BioSpace
Wed, 08/16/23 - 11:35 am
Stada
M&A
Peter Goldschmidt
How Biogen outbid a rival 'large-cap' pharma to claim Reata for $7.3B
Fierce Pharma
Tue, 08/15/23 - 11:53 am
Biogen
Reata Pharmaceuticals
M&A
Skyclarys
Friedreich’s ataxia
Harmony Makes Rare Disease Play with Potential $200M Zynerba Buyout
BioSpace
Tue, 08/15/23 - 11:36 am
Harmony Biosciences
Zynerba
M&A
neuropsychiatric
Eli Lilly and Company completes acquisition of Versanis Bio
Pharmaceutical Business Review
Tue, 08/15/23 - 10:01 am
Eli Lilly
Versanis Bio
M&A
SEC Investigating Illumina’s Multi-Billion Dollar Merger with GRAIL
BioSpace
Fri, 08/11/23 - 11:40 am
SEC
Illumina
Grail
M&A
cancer
diagnostics
Novo Nordisk bets $1.1B on Canadian biotech buyout, adding an old approach to obesity pipeline
Fierce Biotech
Thu, 08/10/23 - 11:41 am
Novo Nordisk
M&A
obesity
Inversago
Could This $6.5 Billion Acquisition Help Turn Biogen's Business Around?
Motley Fool
Thu, 08/10/23 - 09:57 am
Biogen
Reata Pharmaceuticals
M&A
Skyclarys
Proposed Merger Is a Match Made in AI
Medical Devices and Diagnostics Industry
Wed, 08/9/23 - 10:30 pm
Renovaro BioSciences
Gedi Cube
M&A
artificial intelligence
Regeneron adds Decibel to gene therapy playlist, turning up volume on long-running hearing loss collaboration
Fierce Biotech
Wed, 08/9/23 - 10:10 am
Regeneron
hearing loss
Decibel Therapeutics
gene therapy
M&A
Bausch + Lomb's Saunders doesn't expect more big deals in the near term
Reuters
Fri, 08/4/23 - 10:19 am
Bausch + Lomb
Pharma CEOs
Brent Saunders
earnings
M&A
Biogen looks at selling biosims unit to longtime ally Samsung Bioepis: reports
Fierce Pharma
Thu, 08/3/23 - 09:59 am
Biogen
biosimilars
M&A
Samsung Bioepis

Pages